Core Viewpoint - The company, Meai (China) Environmental Technology Co., Ltd., is positioned as a leading player in the domestic semiconductor cleanroom equipment market, focusing on air purification products and environmental governance solutions [2][3]. Company Overview - Meai specializes in the research, production, and sales of air purification products and atmospheric environmental governance products, with its main products including fan filter units, filters, and air purification equipment [3][7]. - The company was awarded the national-level "specialized and innovative" title of "little giant" at the end of 2021, solidifying its status as a leader in the domestic electronic semiconductor cleanroom equipment sector [3]. Financial Performance - For the first half of 2025, Meai achieved operating revenue of 935 million yuan, representing a year-on-year growth of 23.51%, and a net profit attributable to shareholders of 98.02 million yuan, which is a 5.53% increase compared to the previous year [7][8]. - The company has distributed a total of 80.64 million yuan in dividends since its A-share listing [9]. Market Position and Supply Chain - Meai has developed the first domestic 28nm lithography equipment and provides essential air purification products to major semiconductor manufacturers, including Intel and ST Microelectronics, positioning itself competitively against international brands [2][3]. - The company has long-term supply agreements with SMIC, providing various filtration products to meet the stringent air cleanliness requirements of advanced semiconductor manufacturing processes [2][3]. Stock Performance - As of October 21, the stock price of Meai increased by 1.53%, with a trading volume of 73.52 million yuan and a market capitalization of 5.985 billion yuan [1]. - The average trading cost of the stock is 50.52 yuan, with recent trading activity indicating a potential shift in investor sentiment as the stock approaches a resistance level of 45.00 yuan [5][6].

Core Viewpoint - The signing of the cooperation framework agreement between the company and Roche Diagnostics is a strategic move to enhance brand recognition and expand market share in the diagnostic reagent field [1] Group 1: Cooperation Agreement - The cooperation framework agreement is a non-binding statement of intent between the company and Roche Diagnostics [1] - The agreement does not impose legal obligations or grounds for liability for breach of contract [1] Group 2: Strategic Importance - The signing of the agreement is an important step in implementing the company's long-term development strategy [1] - Collaboration with Roche Diagnostics is expected to positively impact the company's development by enhancing brand recognition in the local market [1] Group 3: Market Expansion - The partnership aims to further expand the company's market share in the diagnostic reagent sector [1] - The collaboration will facilitate mutual learning and communication, leading to improved product quality and services for customers [1]

Core Viewpoint - The company announced the cancellation of a portion of unvested restricted stock due to the departure of one incentive recipient, resulting in a total of 16,766 shares being voided, which will not significantly impact the company's operations or the stability of its management team [5][6][7]. Group 1: Restricted Stock Incentive Plan - The company approved the restricted stock incentive plan on August 26, 2024, with a total of 4.032 million shares to be granted, representing 3% of the company's total share capital at the time [21][24]. - The first grant of 3.2256 million shares accounted for 80% of the total incentive plan, with a grant price of 15.40 yuan per share [21][34]. - The plan includes performance assessment criteria, with the company-level vesting ratio set at 80% and individual assessments determining the final vesting amounts [6][31]. Group 2: Cancellation of Restricted Stock - The cancellation of 1,676.6 shares was due to one incentive recipient's departure and the failure to meet performance criteria for some individuals [5][6][31]. - The total number of incentive recipients was adjusted from 14 to 13 following the cancellation [5][6]. - The company confirmed that the cancellation would not affect the ongoing implementation of the incentive plan or the stability of its technical and management teams [7][40]. Group 3: Legal and Compliance - The legal opinion from Shanghai Junlan Law Firm confirmed that the cancellation and vesting processes complied with relevant regulations and internal governance [8][40]. - The company has fulfilled its disclosure obligations regarding the incentive plan and will continue to adhere to regulatory requirements [8][40].

证券日报网讯 10月20日晚间，美埃科技发布公告称，公司于2025年10月20日召开的第二届董事会第二 十四次会议审议通过了《关于作废部分已授予尚未归属的限制性股票的议案》。 （文章来源：证券日报） ...

证券代码：688376 证券简称：美埃科技 公告编号：2025-039 美埃（中国）环境科技股份有限公司 关于作废部分已授予尚未归属的限制性股票的公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 美埃（中国）环境科技股份有限公司（以下简称"公司"）于 2025 年 10 月 20 日召开的第二届董事会第二十四次会议审议通过了《关于作废部分已授予尚 未归属的限制性股票的议案》，现将相关事项公告如下： 一、本次限制性股票激励计划已履行的决策程序和信息披露情况 1、2024 年 8 月 26 日，公司第二届董事会薪酬与考核委员会第二次会议审议 通过了《关于公司<2024 年限制性股票激励计划（草案）>及其摘要的议案》及 《关于公司<2024 年限制性股票激励计划实施考核管理办法>的议案》。 同日，公司召开第二届董事会第十三次会议，会议审议通过了《关于公司 <2024 年限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2024 年 限制性股票激励计划实施考核管理办法>的议案》《关于提请股东大会授权董事 会办理公司 202 ...

证券代码：688376 证券简称：美埃科技 公告编号：2025-040 美埃（中国）环境科技股份有限公司 2024 年限制性股票激励计划第一次预留授予部分 第一个归属期符合归属条件的公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、本次股权激励计划批准及实施情况 （一）本次股权激励计划方案及履行的程序 本次拟归属的限制性股票数量：2.5894 万股 归属股票来源：公司向激励对象定向发行公司 A 股普通股股票 | 首次授予的限制性股票 | 自首次授予之日起 | 个月后的首个交易日至首 12 | 34.00% | | --- | --- | --- | --- | | 第一个归属期 | 次授予之日起 24 | 个月内的最后一个交易日止 | | | 首次授予的限制性股票 | 自首次授予之日起 | 个月后的首个交易日至首 24 | 33.00% | | 第二个归属期 | 次授予之日起 36 | 个月内的最后一个交易日止 | | | 首次授予的限制性股票 | 自首次授予之日起 | 个月后的首个交易日至首 36 ...

上海君澜律师事务所 关于 美埃（中国）环境科技股份有限公司 2024 年限制性股票激励计划 作废部分限制性股票及归属条件成就 之 法律意见书 二〇二五年十月 上海君澜律师事务所 法律意见书 上海君澜律师事务所 关于美埃（中国）环境科技股份有限公司 2024 年限制性股票激励计划 作废部分限制性股票及归属条件成就之 法律意见书 致：美埃（中国）环境科技股份有限公司 对本法律意见书，本所律师声明如下： （一）本所律师依据《中华人民共和国证券法》《律师事务所从事证券法 律业务管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及 本法律意见书出具日以前已经发生或者存在的事实，严格履行了法定职责，遵 循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保证本法律意见所认 定的事实真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记 载、误导性陈述或者重大遗漏，并承担相应法律责任。 （二）本所已得到美埃科技如下保证：美埃科技向本所律师提供了为出具 本法律意见书所必需的全部文件，所有文件真实、完整、合法、有效，所有文 件的副本或复印件均与正本或原件相符，所有文件上的签名、印章均为真实； 且一切足以影响本所律 ...

证券代码：688376 证券简称：美埃科技 公告编号：2025-041 美埃（中国）环境科技股份有限公司 第二届董事会第二十四次会议决议公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 美埃（中国）环境科技股份有限公司（以下简称"公司"）第二届董事会第 二十四次会议于 2025 年 10 月 20 日以现场及通讯相结合的方式召开。本次会议 通知已于 2025 年 10 月 17 日以邮件的方式发出。本次会议由公司董事长蒋立先 生主持，本次会议应出席董事 7 名，实际出席董事 7 名。本次会议的召集、召开 方式符合有关法律、法规和《美埃（中国）环境科技股份有限公司章程》的规 定。 二、董事会会议审议情况 （一）审议通过《关于作废部分已授予尚未归属的限制性股票的议案》 表决结果：同意 7 票，反对 0 票，弃权 0 票。 本议案已经薪酬与考核委员会审议通过。 1 （二）审议通过《2024年限制性股票激励计划第一次预留授予部分第一个归 属期符合归属条件的议案》 根据《激励计划》规定的归属条件，董事会认为 ...

关于公司 2024 年限制性股票激励计划 本次拟归属的激励对象符合《公司法》《证券法》等法律、法规和规范性文 件以及《公司章程》规定的任职资格，符合《管理办法》《上市规则》等法律、 法规和规范性文件规定的激励对象条件，符合本次激励计划规定的激励对象范围， 其作为公司本次激励计划激励对象的主体资格合法、有效，激励对象获授限制性 股票的归属条件已成就。 美埃（中国）环境科技股份有限公司 美埃（中国）环境科技股份有限公司董事会薪酬与考核委员会 董事会薪酬与考核委员会 2025 年 10 月 20 日 第一次预留授予部分第一个归属期归属名单的核查 意见 美埃（中国）环境科技股份有限公司（以下简称"公司"）董事会薪酬与考核 委员会依据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和 国证券法》（以下简称"《证券法》"）《上市公司股权激励管理办法》（以下简称"《管 理办法》"）《上海证券交易所科创板股票上市规则》（以下简称"《上市规则》"） 等相关法律、法规及规范性文件和《美埃（中国）环境科技股份有限公司章程》 （以下简称"《公司章程》"）的有关规定对公司 2024 年限制性股票激励计划（以 下简称"本次 ...

Core Viewpoint - The company, Meai (China) Environmental Technology Co., Ltd., is positioned as a leading domestic brand in the air purification and environmental governance sector, particularly in the semiconductor industry, with significant growth potential due to its advanced technology and strong market presence [2][3]. Company Overview - Meai specializes in the research, production, and sales of air purification products and atmospheric environmental governance products, with its main products including fan filter units, filters, and air purification equipment [3][7]. - The company was awarded the national-level "specialized and innovative" title of "little giant" at the end of 2021, establishing itself as a leader in cleanroom equipment for the electronics semiconductor sector [3]. Financial Performance - For the first half of 2025, Meai achieved a revenue of 935 million yuan, representing a year-on-year growth of 23.51%, and a net profit attributable to shareholders of 98.01 million yuan, with a year-on-year increase of 5.53% [7][8]. - The company has distributed a total of 80.64 million yuan in dividends since its A-share listing [9]. Market Position and Clientele - Meai has developed the first domestic 28nm lithography equipment and provides high-efficiency air purification products to major international semiconductor manufacturers such as Intel and ST Microelectronics, indicating its competitive standing in the market [2][3]. - The company has long-term supply agreements with SMIC, providing essential air purification products to meet the stringent cleanliness requirements of advanced semiconductor manufacturing processes [2][3]. Stock Performance - As of October 20, the stock price of Meai increased by 0.60%, with a total market capitalization of 5.895 billion yuan and a trading volume of 75.42 million yuan [1]. - The stock has experienced a net outflow of 5.05 million yuan from major investors, indicating a trend of reduced holdings over the past three days [4][5].